FLORENCE, Alabama - All of the nearly 2,900 lawsuits claiming pharmaceutical giant Pfizer Inc.'s smoking cessation drug Chantix triggered suicidal thoughts and other psychological problems in patients have been settled - for about $300 million - so the nationwide litigation should now be dismissed, a federal judge in Alabama ruled Monday.
Despite the end to those lawsuits, Pfizer next week will continue its fight with the U.S. Food and Drug Administration for a less severe warning label for Chantix.
U.S. District Court Judge Inge Johnson on Monday held the final status conference in the litigation at the federal courthouse in Florence.
Help employers find you! Check out all the jobs and post your resume.
